Citadel Advisors
NITE

Citadel Advisors’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Citadel Advisors’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-21,666
Closed -$249K – 10233
2018
Q4 		$249K Sell
21,666
-45,299
-68% -$603K ﹤0.01% 7553
2018
Q3 		$1.37M Buy
+66,965
New +$1.37M ﹤0.01% 5020
2017
Q4 		– Sell
-12,500
Closed -$240K – 8704
2017
Q3 		$240K Buy
+12,500
New +$270K ﹤0.01% 6417

Other funds holding NITE

TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Citadel Advisors's NITE Position: Q1 2019 in Review

Citadel Advisors sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q1 2019, closing a stake of 21,666 shares — an estimated $249K sold.

Citadel Advisors first reported a position in NITE in Q3 2017 and held it in 3 quarters. The position peaked at $1.37M in Q3 2018. 53 funds tracked by Wall St. Rank hold NITE as of Q1 2019.

  • Citadel Advisors reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q1 2019 after selling out during the quarter.
  • Citadel Advisors sold 21,666 Nightstar Therapeutics plc American Depositary Shares shares in Q1 2019, an estimated $249K.
  • Citadel Advisors first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 3 quarters.
  • Citadel Advisors's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.37M in Q3 2018.
  • 53 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q1 2019.

Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.